Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ · Healthcare
Regeneron Pharmaceuticals, Inc. EPS 2008–2025
Regeneron Pharmaceuticals, Inc. annual/quarterly eps history and growth rate from 2010 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Regeneron Pharmaceuticals, Inc. eps for the quarter ending March 31, 2026 was $6.75, a 7.15% decrease year-over-year.
- Regeneron Pharmaceuticals, Inc. annual eps for 2025 was $41.48, a 8.19% increase from 2024.
- Regeneron Pharmaceuticals, Inc. annual eps for 2024 was $38.34, a 10.27% increase from 2023.
- Regeneron Pharmaceuticals, Inc. annual eps for 2023 was $34.77, a 9.03% decrease from 2022.
- Regeneron Pharmaceuticals, Inc. annual eps for 2022 was $38.22.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Regeneron Pharmaceuticals Inc. EPS — FAQ
Regeneron Pharmaceuticals Inc. (REGN) eps over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
What is Regeneron Pharmaceuticals Inc.'s eps?
Regeneron Pharmaceuticals Inc. (REGN) reported eps of $41.48 for fiscal 2025.
Where can I see REGN's eps history?
The chart and table above show Regeneron Pharmaceuticals Inc.'s eps by year and by quarter, including the growth rate.